Cargando…
Correction: Unfractionated heparin versus nafamostat mesylate for anticoagulation during continuous kidney replacement therapy: an observational study
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881303/ https://www.ncbi.nlm.nih.gov/pubmed/36703103 http://dx.doi.org/10.1186/s12882-023-03067-8 |
| _version_ | 1784879082844979200 |
|---|---|
| author | Kameda, Shinya Fujii, Tomoko Ikeda, Junpei Kageyama, Akira Takagi, Toshishige Miyayama, Naoki Asano, Kengo Endo, Arata Uezono, Shoichi |
| author_facet | Kameda, Shinya Fujii, Tomoko Ikeda, Junpei Kageyama, Akira Takagi, Toshishige Miyayama, Naoki Asano, Kengo Endo, Arata Uezono, Shoichi |
| author_sort | Kameda, Shinya |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9881303 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98813032023-01-28 Correction: Unfractionated heparin versus nafamostat mesylate for anticoagulation during continuous kidney replacement therapy: an observational study Kameda, Shinya Fujii, Tomoko Ikeda, Junpei Kageyama, Akira Takagi, Toshishige Miyayama, Naoki Asano, Kengo Endo, Arata Uezono, Shoichi BMC Nephrol Correction BioMed Central 2023-01-26 /pmc/articles/PMC9881303/ /pubmed/36703103 http://dx.doi.org/10.1186/s12882-023-03067-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Kameda, Shinya Fujii, Tomoko Ikeda, Junpei Kageyama, Akira Takagi, Toshishige Miyayama, Naoki Asano, Kengo Endo, Arata Uezono, Shoichi Correction: Unfractionated heparin versus nafamostat mesylate for anticoagulation during continuous kidney replacement therapy: an observational study |
| title | Correction: Unfractionated heparin versus nafamostat mesylate for anticoagulation during continuous kidney replacement therapy: an observational study |
| title_full | Correction: Unfractionated heparin versus nafamostat mesylate for anticoagulation during continuous kidney replacement therapy: an observational study |
| title_fullStr | Correction: Unfractionated heparin versus nafamostat mesylate for anticoagulation during continuous kidney replacement therapy: an observational study |
| title_full_unstemmed | Correction: Unfractionated heparin versus nafamostat mesylate for anticoagulation during continuous kidney replacement therapy: an observational study |
| title_short | Correction: Unfractionated heparin versus nafamostat mesylate for anticoagulation during continuous kidney replacement therapy: an observational study |
| title_sort | correction: unfractionated heparin versus nafamostat mesylate for anticoagulation during continuous kidney replacement therapy: an observational study |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881303/ https://www.ncbi.nlm.nih.gov/pubmed/36703103 http://dx.doi.org/10.1186/s12882-023-03067-8 |
| work_keys_str_mv | AT kamedashinya correctionunfractionatedheparinversusnafamostatmesylateforanticoagulationduringcontinuouskidneyreplacementtherapyanobservationalstudy AT fujiitomoko correctionunfractionatedheparinversusnafamostatmesylateforanticoagulationduringcontinuouskidneyreplacementtherapyanobservationalstudy AT ikedajunpei correctionunfractionatedheparinversusnafamostatmesylateforanticoagulationduringcontinuouskidneyreplacementtherapyanobservationalstudy AT kageyamaakira correctionunfractionatedheparinversusnafamostatmesylateforanticoagulationduringcontinuouskidneyreplacementtherapyanobservationalstudy AT takagitoshishige correctionunfractionatedheparinversusnafamostatmesylateforanticoagulationduringcontinuouskidneyreplacementtherapyanobservationalstudy AT miyayamanaoki correctionunfractionatedheparinversusnafamostatmesylateforanticoagulationduringcontinuouskidneyreplacementtherapyanobservationalstudy AT asanokengo correctionunfractionatedheparinversusnafamostatmesylateforanticoagulationduringcontinuouskidneyreplacementtherapyanobservationalstudy AT endoarata correctionunfractionatedheparinversusnafamostatmesylateforanticoagulationduringcontinuouskidneyreplacementtherapyanobservationalstudy AT uezonoshoichi correctionunfractionatedheparinversusnafamostatmesylateforanticoagulationduringcontinuouskidneyreplacementtherapyanobservationalstudy |